{"disease":{"id":"multifocal-motor-neuropathy","name":"multifocal motor neuropathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06040567","title":"Polyneuropathy, Impairments and Physical Activity - The PolyImPAct Study","phase":"","overall_status":"RECRUITING","enrollment_count":520,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT05988073","title":"A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":413,"lead_sponsor_name":"argenx","has_results":false},{"nct_id":"NCT05225675","title":"A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults with Multifocal Motor Neuropathy","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"argenx","has_results":false},{"nct_id":"NCT05405361","title":"A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":51,"lead_sponsor_name":"argenx","has_results":false},{"nct_id":"NCT00666263","title":"Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Baxalta now part of Shire","has_results":true},{"nct_id":"NCT06537999","title":"A Clinical Study to Evaluate DNTH103 in Adults With Multifocal Motor Neuropathy","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Dianthus Therapeutics","has_results":false},{"nct_id":"NCT05084053","title":"A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":26,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT04356781","title":"Do IgG Level Variations in CIDP and MMN Patients Following Initial Intravenous IVIg Treatment Correlate With Ultimate Dosing","phase":"","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Walton Centre NHS Foundation Trust","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}